Metraipolis › archive › dc_e83704c4de40

Adjuvant Icotinib in EGFR-mutated stage IB non-small cell lung cancer with high-risk factors: A retrospective case series — Europe PMC PMID:41259381

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41259381
DOI
10.1371/journal.pone.0337237
License (as archived)
solo-consultazione
Archived
2026-11-08T10:37:38.013Z
SHA-256 of the archived text
c4a62edf6792b1468904282f38b6505210edccb968e618283ecc3a3e1af85ce6
Stable URL of this page
https://metraipolis.com/documento/dc_e83704c4de40

How to cite

Adjuvant Icotinib in EGFR-mutated stage IB non-small cell lung cancer with high-risk factors: A retrospective case series — Europe PMC PMID:41259381 — Europe PMC (en), https://europepmc.org/article/MED/41259381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e83704c4de40 (Metraipolis archive dc_e83704c4de40, sha256 c4a62edf6792b1468904282f38b6505210edccb968e618283ecc3a3e1af85ce6)
BibTeX
@misc{dce83704c4de40,
  title = {Adjuvant Icotinib in EGFR-mutated stage IB non-small cell lung cancer with high-risk factors: A retrospective case series — Europe PMC PMID:41259381},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41259381},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e83704c4de40; sha256 c4a62edf6792b1468904282f38b6505210edccb968e618283ecc3a3e1af85ce6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41259381. Agents can read the archived copy with the MCP tool read_document.